Skip to content

Drug interactions

Quinidine + Repotrectinib

Severity: Major

Quinidine and Repotrectinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Repotrectinib induces CYP3A4 and is expected to markedly lower quinidine exposure, reducing efficacy. Quinidine may in turn increase repotrectinib levels through P-glycoprotein inhibition.

What this interaction means in plain words

Quinidine and Repotrectinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Quinidine belongs to Anti Parasitic; Repotrectinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Repotrectinib induces CYP3A4 and P-glycoprotein, while quinidine inhibits P-glycoprotein.

What to do

Avoid the combination. If it is unavoidable, monitor quinidine concentrations and ECG and watch for repotrectinib toxicity.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Quinidine and Repotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Quinidine with Repotrectinib?

MediHelp rates the interaction as major. Quinidine and Repotrectinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Repotrectinib induces CYP3A4 and is expected to markedly lower quinidine exposure, reducing efficacy. Quinidine may in turn increase repotrectinib levels through P-glycoprotein inhibition.

How serious is the interaction between Quinidine and Repotrectinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination. If it is unavoidable, monitor quinidine concentrations and ECG and watch for repotrectinib toxicity.

What other medicines interact with Quinidine?

MediHelp also lists interactions of Quinidine with, for example, Adagrasib, Arsenic trioxide, Artemether / lumefantrine. The full list is on the Quinidine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in